Utility of a fusion protein T-cell co-stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume center

Oren, D., Uriel, M., Moeller, C. M., Valledor, A. F., DeFilippis, E. M., Lotan, D., Colombo, P. C., Yuzefpolskaya, M., Topkara, V. K., Clerkin, K. J., Raikhelkar, J. K., Fried, J. A., Oh, D. (Kyung T., Bae, D., Lin, E., Theodoropoulos, K., Naka, Y., Takeda, K., Choe, J., … Uriel, N. (2024). Utility of a fusion protein T‐cell co‐stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume center. Clinical Transplantation, 38(3). Portico. https://doi.org/10.1111/ctr.15251
Authors:
Daniel Oren
Matan Uriel
Cathrine M Moeller
Andrea Fernandez Valledor
Ersilia M DeFilippis
Dor Lotan
Paolo C Colombo
Melana Yuzefpolskaya
Veli K Topkara
Kevin J Clerkin
Jayant K Raikhelkar
Justin A Fried
David Kyung Taek Oh
David Bae
Eddie Lin
Kleanthis Theodoropoulos
Yoshifumi Naka
Koji Takeda
Jason Choe
Douglas L Jennings
David Majure
Farhana Latif
Gabriel Sayer
Nir Uriel
Affiliated Authors:
Daniel Oren
Matan Uriel
Cathrine M Moeller
Andrea Fernandez Valledor
Ersilia M DeFilippis
Dor Lotan
Paolo C Colombo
Melana Yuzefpolskaya
Veli K Topkara
Kevin J Clerkin
Jayant K Raikhelkar
Justin A Fried
David Kyung Taek Oh
David Bae
Eddie Lin
Kleanthis Theodoropoulos
Yoshifumi Naka
Koji Takeda
Jason Choe
Douglas L Jennings
Farhana Latif
Gabriel Sayer
Nir Uriel
Author Keywords:
belatacept
graft rejection
heart transplantation
immunosuppression
kidney failure
Publication Type:
Article
Unique ID:
10.1111/ctr.15251
PMID:
Publication Date:
Data Source:
PubMed

Record Created: